Trial intelligence / Profile preview

Delgocitinib Ointment in Alopecia Areata

NCT02561585Phase 2Completed

Sponsor
LEO Pharma
Start
Jan 2016
Primary completion
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of delgocitinib in alopecia areata, sponsored by LEO Pharma. Started Jan 2016; status: completed.

02

Drugs

delgocitinib
03

Conditions

alopecia areata

Beyond the preview

Go deeper on NCT02561585.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02561585.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call